FIG 2.
Validation of the physiologically based pharmacokinetic model strategy against clinical data of TDF once-daily, day 7 profiles for dose sizes of 300 mg (A), 75 mg (B), 150 mg (C), and 600 mg (D). Data are from reference 6.
Validation of the physiologically based pharmacokinetic model strategy against clinical data of TDF once-daily, day 7 profiles for dose sizes of 300 mg (A), 75 mg (B), 150 mg (C), and 600 mg (D). Data are from reference 6.